Archford Capital Strategies’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,364
| Closed | -$209K | – | 305 |
|
|
2021
Q1 | $209K | Buy |
+1,364
| New | +$209K | 0.06% | 259 |
|
|
2019
Q3 | – | Sell |
-2,128
| Closed | -$232K | – | 357 |
|
|
2019
Q2 | $232K | Sell |
2,128
-451
| -17% | -$49.2K | 0.08% | 200 |
|
|
2019
Q1 | $288K | Sell |
2,579
-4,850
| -65% | -$542K | 0.11% | 195 |
|
|
2018
Q4 | $716K | Sell |
7,429
-2,616
| -26% | -$252K | 0.29% | 104 |
|
|
2018
Q3 | $1.23M | Sell |
10,045
-749
| -7% | -$91.3K | 0.45% | 62 |
|
|
2018
Q2 | $1.19M | Sell |
10,794
-1,388
| -11% | -$152K | 0.42% | 72 |
|
|
2018
Q1 | $1.3M | Buy |
12,182
+69
| +0.6% | +$7.37K | 0.54% | 58 |
|
|
2017
Q4 | $1.29M | Sell |
12,113
-853
| -7% | -$91.1K | 0.48% | 59 |
|
|
2017
Q3 | $1.44M | Sell |
12,966
-63
| -0.5% | -$7.01K | 0.54% | 61 |
|
|
2017
Q2 | $1.35M | Buy |
13,029
+156
| +1% | +$16.1K | 0.53% | 62 |
|
|
2017
Q1 | $1.26M | Buy |
12,873
+369
| +3% | +$36.1K | 0.47% | 64 |
|
|
2016
Q4 | $1.11M | Buy |
12,504
+144
| +1% | +$12.7K | 0.47% | 76 |
|
|
2016
Q3 | $1.19M | Buy |
12,360
+216
| +2% | +$20.8K | 0.49% | 65 |
|
|
2016
Q2 | $1.04M | Buy |
12,144
+297
| +3% | +$25.5K | 0.55% | 55 |
|
|
2016
Q1 | $1.03M | Buy |
11,847
+2,967
| +33% | +$258K | 0.49% | 64 |
|
|
2015
Q4 | $1M | Buy |
8,880
+189
| +2% | +$21.3K | 0.46% | 69 |
|
|
2015
Q3 | $879K | Sell |
8,691
-195
| -2% | -$19.7K | 0.66% | 45 |
|
|
2015
Q2 | $1.09M | Buy |
8,886
+309
| +4% | +$38K | 0.78% | 32 |
|
|
2015
Q1 | $982K | Sell |
8,577
-1,566
| -15% | -$179K | 0.68% | 48 |
|
|
2014
Q4 | $1.03M | Buy |
10,143
+126
| +1% | +$12.7K | 0.75% | 36 |
|
|
2014
Q3 | $914K | Buy |
10,017
+696
| +7% | +$63.5K | 0.73% | 31 |
|
|
2014
Q2 | $799K | Buy |
9,321
+1,698
| +22% | +$145K | 0.62% | 50 |
|
|
2014
Q1 | $601K | Buy |
+7,623
| New | +$601K | 0.5% | 65 |
|